Quinto. When sleepiness had no name.

The case

On 26 July 2016, on the A2 motorway near Quinto, Leventina, a vehicle rear-ended a car stationary in a queue. The medical assessment ordered by the cantonal criminal court established that the driver was suffering from severe obstructive sleep apnoea syndrome he was unaware of. No alcohol, no distraction: a real danger that, at the time, no test could measure.

Why we are publishing this

We are not presenting it as a commemoration. The tenth anniversary is an occasion to open a public debate on a still under-recognised road risk: sleepiness at the wheel and the sleep disorders that can cause it. The aim is concrete: to recognise these disorders better as a possible risk factor, to encourage specialist assessment in suspected cases, and to support research into objective indicators. An invitation to those who drive, those who treat and those who work in road safety to look at this danger before it leaves a trace.

From apnoea to microsleep

Obstructive sleep apnoea repeatedly interrupts breathing during the night and fragments rest. In some people it can cause pronounced daytime sleepiness and increase the risk of microsleep at the wheel - brief, involuntary sleep episodes of a few seconds. It is a condition that can remain undiagnosed for years. At the wheel, a few seconds are enough.

The IRM Zürich study

In June 2026, just weeks before the tenth anniversary, the Institute of Forensic Medicine at the University of Zurich (IRM Zürich), Drive Awake's scientific partner, published a promising result in the Journal of Proteome Research. In twenty healthy young men, across three controlled conditions - one night without sleep, four nights of sleep reduced to six hours and one night of normal rest - a machine-learning classifier distinguished acute sleep deprivation on the basis of twelve molecular features in oral fluid. These features do not amount to twelve identified metabolites. The four nights of six-hour sleep, by contrast, produced only weak metabolic changes. It is a possible biochemical signature for a condition that until now left no trace. DOI: 10.1021/acs.jproteome.5c01064.

What it does not yet say

It is a laboratory proof of concept, on a small group of healthy volunteers. It is not a validated roadside test, it does not diagnose sleep apnoea, and it cannot reconstruct after the fact what happened at Quinto. The study measures acute sleep deprivation under experimental conditions, not sleepiness at the wheel in real life. The next planned step is a large international field study, to validate it under realistic conditions. For a danger that today leaves no trace, it is a direction.

The proposals

Prof. Mauro Manconi, head of the Sleep Medicine Centre at EOC Neurocentro and scientific adviser to Drive Awake, points to two concrete directions. Clinical prevention: consider proportionate screening for sleep disorders within driving fitness, with particular attention to professional drivers and to cases following a crash consistent with a microsleep. Specialist assessment: where a sleep disorder is suspected, connect traffic medicine with sleep-medicine specialists and with the Swiss network of SSSSC-certified centres. Not mandatory screening for every licence, but targeted collaboration where the risk is most concrete.

For clarity

Criminal proceedings: acquittal, which became final after the Public Prosecutor's Office declined to appeal. That outcome does not imply a broader civil or factual conclusion about the event. The release gives no nationality, age or details of those involved: out of respect, and because the point is not the court case but the danger it makes visible.